TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS · Delayed Price · Currency is USD
0.0710
0.00 (0.00%)
At close: Jan 27, 2026
TC Biopharm (Holdings) Employees
TC Biopharm (Holdings) had 39 employees as of December 31, 2024. The number of employees decreased by 2 or -4.88% compared to the previous year.
Employees
39
Change (1Y)
-2
Growth (1Y)
-4.88%
Revenue / Employee
n/a
Profits / Employee
-$390,152
Market Cap
149.32K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 39 | -2 | -4.88% |
| Dec 31, 2023 | 41 | -19 | -31.67% |
| Dec 31, 2022 | 60 | -16 | -21.05% |
| Dec 31, 2021 | 76 | -4 | -5.00% |
| Dec 31, 2020 | 80 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Scorpius Holdings | 91 |
| Synairgen | 34 |
| Vincerx Pharma | 13 |
| Ocean Biomedical | 7 |
| Ampio Pharmaceuticals | 6 |
| Innovation Pharmaceuticals | 4 |
| GB Sciences | 2 |
| CNBX Pharmaceuticals | 1 |
TC Biopharm (Holdings) News
- 8 months ago - TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient - PRNewsWire
- 10 months ago - TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells - PRNewsWire
- 11 months ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
- 11 months ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
- 11 months ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
- 1 year ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
- 1 year ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
- 1 year ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire